The agreement includes a new $25 million term loan that accrues interest at a rate per annum equal to one-month term SOFR plus 8% and matures on June 30, 2026. 

The agreement also provides certain covenant relief, including a waiver of the $30 million minimum liquidity covenant until the first week ending after July 1, 2026 and forbearance by existing lenders from exercising rights and remedies with respect to other financial covenants. 

In addition, the agreement includes certain milestones related to Sleep Number's efforts to finalize a strategic transaction that maximizes enterprise value and provides payment in full of the obligations owed to its lenders. 

Additional details regarding the agreement, including the terms of the new term loan and related covenant relief, are available in the company's Current Report on Form 8-K filed with the Securities and Exchange Commission.